tiprankstipranks
Trending News
More News >
Abattis Bioceuticals (ATTBF)
:ATTBF
US Market
Advertisement

Abattis Bioceuticals (ATTBF) Income Statement

Compare
174 Followers

Abattis Bioceuticals Income Statement

Last quarter (Q4 2019), Abattis Bioceuticals's total revenue was C$226.27K, an increase of 9064.32% from the same quarter last year. In Q4, Abattis Bioceuticals's net income was C$-907.06K. See Abattis Bioceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 19Sep 18Sep 17Sep 16
Total Revenue
C$ 356.88KC$ 8.37KC$ 0.00C$ 0.00
Gross Profit
C$ 241.34KC$ 6.48KC$ 0.00C$ 0.00
Operating Expenses
C$ 4.26MC$ 15.84MC$ 6.36MC$ 2.31M
Depreciation and Amortization
C$ 109.01KC$ 37.36KC$ 90.95KC$ 130.03K
EBITDA
C$ -3.85MC$ -17.34MC$ -5.34MC$ -2.13M
Operating Income
C$ -3.96MC$ -17.37MC$ -6.36MC$ -2.31M
Other Income/Expenses
C$ 895.80KC$ -61.82MC$ -688.46KC$ -280.56K
Pretax Income
C$ -3.06MC$ -77.65MC$ -7.93MC$ -2.41M
Net Income
C$ -3.04MC$ -78.01MC$ -7.63MC$ -2.34M
Per Share Metrics
Basic EPS
C$ -0.01C$ -0.24C$ -0.05C$ -0.02
Diluted EPS
C$ -0.01C$ -0.24C$ -0.05C$ -0.02
Weighted Average Shares Outstanding
470.49M 322.64M 148.67M 95.00M
Weighted Average Shares Outstanding (Diluted)
470.49M 322.64M 148.67M 95.00M
Currency in CAD

Abattis Bioceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis